Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Alessia Giorgini"'
Autor:
Giuseppina Brancaccio, Barbara Coco, Alessandra Nardi, Maria Giovanna Quaranta, Maria Elena Tosti, Luigina Ferrigno, Irene Cacciola, Vincenzo Messina, Luchino Chessa, Filomena Morisco, Michele Milella, Francesco Barbaro, Alessia Ciancio, Francesco Paolo Russo, Nicola Coppola, Pierluigi Blanc, Ernesto Claar, Gabriella Verucchi, Massimo Puoti, Anna Linda Zignego, Liliana Chemello, Salvatore Madonia, Stefano Fagiuoli, Alfredo Marzano, Carlo Ferrari, Pietro Lampertico, Vito Di Marco, Antonio Craxì, Teresa Antonia Santantonio, Giovanni Raimondo, Maurizia R. Brunetto, Giovanni Battista Gaeta, Loreta A. Kondili, Luisa Pasulo, Carmine Coppola, Federica Pisano, Mariarosaria Romano, Carmen Porcu, Irene Francesca Bottalico, Valentina Cossiga, Xhimi Tata, Caterina Sagnelli, Piera Pierotti, Elisabetta Degasperi, Valerio Rosato, Lorenzo Badia, Dontella Ieluzzi, Monica Monti, Maria Grazia Bavetta, Luisa Cavalletto, Pierluigi Toniutto, Ezio Fornasiere, Antonio Colecchia, Alberto Ferrarese, Gerardo Nardone, Alba Rocco, Mauro Viganò, Francesco Giuseppe Foschi, Fabio Conti, Giulia Morsica, Stefania Salpietro, Carlo Torti, Chiara Costa, Alessandro Federico, Marcello Dallio, Alessia Giorgini, Marco Anselmo, Pasqualina De Leo, Serena Zaltron, Anna Cambianica, Fabio Piscaglia, Ilaria Serio, Simona Schivazappa, Antonio Mastroianni, Luciana Chidichimo, Marco Massari, Cesare Mazzaro, Aldo Marrone, Francesca Maria D'Amore, Gianpiero D'Offizi, Anna Licata, Grazia Anna Niro, Teresa Pollicino, Alessio Aghemo
Publikováno v:
International Journal of Infectious Diseases, Vol 129, Iss , Pp 266-273 (2023)
Objectives: The study measures trends in the profile of patients with chronic hepatitis B virus linked to care in Italy. Methods: A cross-sectional, multicenter, observational cohort (PITER cohort) of consecutive patients with hepatitis B surface ant
Externí odkaz:
https://doaj.org/article/7fccc43b31754953bda7d26ec504131e
Autor:
Luca Valenti, Serena Pelusi, Alessio Aghemo, Sara Gritti, Luisa Pasulo, Cristiana Bianco, Claudia Iegri, Giuliana Cologni, Elisabetta Degasperi, Roberta D’Ambrosio, Paolo delPoggio, Alessandro Soria, Massimo Puoti, Isabella Carderi, Marie Graciella Pigozzi, Canio Carriero, Angiola Spinetti, Valentina Zuccaro, Massimo Memoli, Alessia Giorgini, Mauro Viganò, Maria Grazia Rumi, Tiziana Re, Ombretta Spinelli, Maria Chiara Colombo, Tiziana Quirino, Barbara Menzaghi, Gianpaolo Lorini, Angelo Pan, Antonella D’Arminio Monforte, Elisabetta Buscarini, Aldo Autolitano, Paolo Bonfanti, Natalia Terreni, Gianpiero Aimo, Monia Mendeni, Daniele Prati, Pietro Lampertico, Massimo Colombo, Stefano Fagiuoli, for the NAVIGATORE‐Lombardia Network
Publikováno v:
Hepatology Communications, Vol 6, Iss 4, Pp 867-877 (2022)
The aim of this study was to examine the impact of features of dysmetabolism on liver disease severity, evolution, and clinical outcomes in a real‐life cohort of patients treated with direct acting antivirals for chronic hepatitis C virus (HCV) inf
Externí odkaz:
https://doaj.org/article/aa68b6c6c97b421f9c04627e6eb981ed
Autor:
Maria Giovanna Quaranta, Luigina Ferrigno, Xhimi Tata, Franca D’Angelo, Carmine Coppola, Alessia Ciancio, Serena Rita Bruno, Martina Loi, Alessia Giorgini, Marzia Margotti, Valentina Cossiga, Giuseppina Brancaccio, Marcello Dallio, Martina De Siena, Marco Cannizzaro, Luisa Cavalletto, Marco Massari, Maria Mazzitelli, Pasqualina De Leo, Diletta Laccabue, Leonardo Baiocchi, Loreta A. Kondili
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background The development of direct-acting antivirals (DAA) for HCV has revolutionized the treatment of HCV, including its treatment in patients with HIV coinfection. The aim of this study was to compare the changes in liver function betwee
Externí odkaz:
https://doaj.org/article/4dc7ca3cbc6948ee9c85fac1aa0a8d6e
Autor:
Andrea Galassi, Francesca Casanova, Lidia Gazzola, Rocco Rinaldo, Marco Ceresa, Elena Restelli, Alessia Giorgini, Simone Birocchi, Marco Giovenzana, Ulisse Zoni, Federica Valli, Laura Massironi, Sebastiano Belletti, Lorenza Magagnoli, Andrea Stucchi, Michela Ippolito, Stefano Carugo, Elena Parazzini, Mario Cozzolino
Publikováno v:
Clinical Case Reports, Vol 9, Iss 2, Pp 694-703 (2021)
Abstract Without rescue drugs approved, holistic approach by daily hemodialysis, noninvasive ventilation, anti‐inflammatory medications, fluid assessment by bedside ultrasound, and anxiolytics improved outcomes of a maintenance hemodialysis patient
Externí odkaz:
https://doaj.org/article/fe0cc4cf5a2345b5abe386f48465c0ef
Autor:
Loreta A. Kondili, Maria Giovanna Quaranta, Luisa Cavalletto, Vincenza Calvaruso, Luigina Ferrigno, Roberta D'Ambrosio, Ilaria Simonelli, Giuseppina Brancaccio, Giovanni Raimondo, Maurizia R. Brunetto, Anna Linda Zignego, Carmine Coppola, Andrea Iannone, Elisa Biliotti, Gabriella Verucchi, Marco Massari, Anna Licata, Francesco Barbaro, Marcello Persico, Francesco Paolo Russo, Filomena Morisco, Maurizio Pompili, Mauro Viganò, Massimo Puoti, Teresa Santantonio, Erica Villa, Antonio Craxì, Liliana Chemello, Valentina Panetta, Giovanni Battista Gaeta, Roberto Filomia, Barbara Coco, Monica Monti, Daniela Caterina Amoruso, Salvatore Madonia, Donatella Ieluzzi, Gloria Taliani, Lorenzo Badia, Guglielmo Marco Migliorino, Alessia Giorgini, Mario Masarone, Pierluigi Blanc, Valentina Cossiga, Martina De Siena, Xhimi Tata, Maria Grazia Rumi, Luchino Chessa, Pietro Lampertico, Carlo Ferrari, Ivan Gentile, Giustino Parruti, Leonardo Baiocchi, Alessia Ciancio, Pietro Invernizzi, Alessandro Federico, Carlo Torti, Giulia Morsica, Pietro Andreone, Alessio Aghemo, Patrizia Popoli, Stefano Vella
Background and aims: Severe liver disease markers assessed before HCV eradication are acknowledged to usually improve after the SVR. We prospectively evaluated, in the PITER cohort, the long-term HCC risk profile based on predictors monitored after H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::438d10f671907a94a75ee1d3ee7309a9
https://hdl.handle.net/2108/319297
https://hdl.handle.net/2108/319297
Autor:
Michael L Schilsky, Anna Czlonkowska, Massimo Zuin, David Cassiman, Carlos Twardowschy, Aurelia Poujois, Francisco de Assis A Gondim, Gerald Denk, Rubens G Cury, Peter Ott, Joanna Moore, Aftab Ala, Renata D'Inca, Eduardo Couchonnal-Bedoya, Koenraad D'Hollander, Nicolas Dubois, C Omar F Kamlin, Karl Heinz Weiss, Uyen To, Amar Patel, Daksshi Hettiarachchi, Alessia Giorgini, Sara Monico, Tomasz Litwin, Agnieszka Piechal, Marta Skowronska, Alain Lachaux, Abdelouahed Belmalih, Alexandra Boogers, Isabelle Mohr, Andrea Langel, Christian Freitas, Egberto Reis Barbosa, Thomas D Sandahl, Lisbet Gerdes, Alexandre Obadia, Djamila Rahli, Jeremy Cosgrove
Publikováno v:
CHELATE trial investigators 2022, ' Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE) : a randomised, open-label, non-inferiority, phase 3 trial ', The Lancet Gastroenterology and Hepatology, vol. 7, no. 12, pp. 1092-1102 . https://doi.org/10.1016/S2468-1253(22)00270-9
Background: Wilson disease is an inherited disorder of copper transport. Whereas penicillamine is used therapeutically to re-establish copper balance, trientine is indicated for patients with penicillamine intolerance. We aimed to compare penicillami
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc08a6d996987fd1d2dba0c63b14f359
https://pure.au.dk/portal/da/publications/trientine-tetrahydrochloride-versus-penicillamine-for-maintenance-therapy-in-wilson-disease-chelate(ba317b8b-40a9-4b06-9881-6e93f059c2ea).html
https://pure.au.dk/portal/da/publications/trientine-tetrahydrochloride-versus-penicillamine-for-maintenance-therapy-in-wilson-disease-chelate(ba317b8b-40a9-4b06-9881-6e93f059c2ea).html
Autor:
Arianna Dal Buono, Rossella Meli, Federica Lubrano Lobianco, Nicola Pugliese, Massimo Zuin, Alessio Aghemo, Pier Maria Battezzati, Adriano De Santis, Daniela Maggi, Alessia Giorgini, Clara Dibenedetto, Ana Lleo, Antonio Capogreco, S. Monico
Publikováno v:
Expert Opinion on Drug Safety. 20:839-843
Background: Treatment of chronic Hepatitis C with directly acting antivirals (DAAs) can bring to sustained virologic response (SVR) in approximately 95% of patients. Efficacy and safety of DAAs in ...
Autor:
Stefano Carugo, Laura Massironi, Lorenza Magagnoli, Alessia Giorgini, U. Zoni, Simone Birocchi, Francesca Casanova, Elena Maria Parazzini, Michela Ippolito, Rocco Francesco Rinaldo, Lidia Gazzola, Federica Valli, Marco Ceresa, Marco Giovenzana, S. Belletti, Mario Cozzolino, Andrea Galassi, Elena Restelli, Andrea Stucchi
Publikováno v:
Clinical Case Reports, Vol 9, Iss 2, Pp 694-703 (2021)
Clinical Case Reports
Clinical Case Reports
Without rescue drugs approved, holistic approach by daily hemodialysis, noninvasive ventilation, anti‐inflammatory medications, fluid assessment by bedside ultrasound, and anxiolytics improved outcomes of a maintenance hemodialysis patient affected
Autor:
Alessandra Brocchieri, Marta Borghi, Angelo Pan, Mariella Di Marco, Silvia Colombo, Chiara Molteni, Natalia Terreni, Paolo Poggio, Alberto Colombo, De Silvestri Annalisa, Riccardo Centenaro, Luisa Pasulo, Paolo Viganò, Maria Cristina Vinci, Marie Graciella Pigozzi, Stefano Fagiuoli, Pietro Lampertico, Sergio Lazzaroni, Sherrie Bhoori, Massimo Zuin, Franco Noventa, Alessio Aghemo, Barbara Menzaghi, Andrea Lombardi, Franco Maggiolo, I. Fanetti, Alessia Giorgini, Massimo Puoti, Emanuela Messina, Paolo Grossi, Roberta D'Ambrosio, Pietro Invernizzi, Monia Mendeni, Daniele Bella, E. Dionigi, Ombretta Spinelli, Maria Teresa Taddei, Pietro Pozzoni, Antonella d'Arminio Monforte, Elisabetta Buscarini, Angiola Spinetti, Serena Zaltron
Publikováno v:
Digestive and Liver Disease. 52:190-198
Background: Sofosbuvir (SOF)-based regimens have been associated with renal function worsening in HCV patients with estimated glomerular filtration rate (eGFR) ≤ 45 ml/min, but further investigations are lacking. Aim: To assess renal safety in a la
Autor:
Gianpaolo Lorini, Roberta D'Ambrosio, Monia Mendeni, Angelo Pan, Valentina Zuccaro, Canio Carriero, Massimo Colombo, Gianpiero Aimo, Natalia Terreni, Barbara Menzaghi, Massimo Memoli, Alessandro Soria, Aldo Autolitano, Elisabetta Degasperi, Serena Pelusi, M. Puoti, Luca Valenti, Cristiana Bianco, Ombretta Spinelli, Elisabetta Buscarini, Antonella d'Arminio Monforte, Sara Gritti, Paolo Del Poggio, Alessia Giorgini, Tiziana Quirino, T. Re, Marie Graciella Pigozzi, Maria Grazia Rumi, Maria Chiara Colombo, Giuliana Cologni, Daniele Prati, Angiola Spinetti, Stefano Fagiuoli, Mauro Viganò, Isabella Carderi, Luisa Pasulo, Pietro Lampertico, Alessio Aghemo, Paolo Bonfanti, C. Iegri
Publikováno v:
Hepatology communications. 6(4)
The aim of this study was to examine the impact of features of dysmetabolism on liver disease severity, evolution, and clinical outcomes in a real-life cohort of patients treated with direct acting antivirals for chronic hepatitis C virus (HCV) infec